Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched erectile dysfunction drug Viagra in 1998, CEO Albert Bourla said on Monday.
Sign up here.
“Both Lilly and Novo presented their sales and had significant sales outside the reimbursement system. Basically, outside the U.S., we were calculating very limited sales,” Bourla said, speaking to a group of reporters during the J.P. M… [1886 chars]
Source: Reuters | Published: 2026-01-12T23:43:16Z
Credit: Reuters
